KRTX - Karuna's KarXT tops Evaluate's most anticipated drug list
2024-01-29 15:13:38 ET
More on Karuna Therapeutics
- Karuna Therapeutics: Rewiring The Schizophrenia Paradigm - A Novel Leap Beyond Dopamine
- Karuna Therapeutics, Inc. (KRTX) Q3 2023 Earnings Conference Call Transcript
- M&A activity expected to pick up in 2024, bankers say
- Biggest stock movers today: Ansys, Rocket Lab, Nike, Cummins, NetEase and more
- Seeking Alpha’s Quant Rating on Karuna Therapeutics